FDA warns skin care company to stop false advertising

natural beauty products 2 314x210 FDA warns skin care company to stop false advertisingConsumers have many options when pursuing the fountain of youth, especially when it comes to skin care like beauty creams. But the Food and Drug Administration (FDA) has repeatedly advised consumers to use common sense when shopping for products because many make outlandish claims that are in direct violation of the Federal Food, Drug, and Cosmetic Act. Examples are claims that their products can diagnosis, cure, mitigate, treat or prevent disease or are intended to affect the structure or any function of the human body.

The FDA is charged with reviewing promotional material from companies that market cosmetics to ensure they are not misleading the public. Those that are found to be making false claims are issued FDA warning letters.

This month, the FDA issued a warning letter to Annmarie Gianni Skin Care and its founders Annmarie and Kevin Gianni, alleging products sold on its website,, were found to be in violation of the Federal Food, Drug and Cosmetic Act. The products in question are Repair Serum, Anti-Aging Eye Cream, and Anti-Aging Serum. The agency pointed out the following indiscretions:

Repair Serum

  • “Using vegan stem cells…a new way for your skin to build collagen, repair itself and prevent aging.”
  • “Ideal for treating: Sun spots, age spots, acne scarring, Hyperpigmentation.”

Anti-Aging Eye Cream

  • “[S]upports the synthesis of new skin fibers, sweet iris boosts cell regeneration…”
  • “Soothes and reduces redness and irritation.”

Anti-Aging Serum

  • “This serum will increase skin hydration by inhibiting hyalurondase…”
  • “The life everlasting flower extract helps prolong and regenerate the skin cell.”
  • “Sunflower seed extract adds UV protective qualities as well as essential fatty acids.”
  • “Flaxseed is very high in lignans that support cell communication.”
  • “Rosacea”

“Your products are not generally recognized as safe and effective for the above referenced uses,” the agency wrote in the July 15, 2016, warning letter. “It is your responsibility to ensure that all products marketed by your firm comply with the Act and its implementing regulations. We advise you to review your website, product labels, and other labeling for your products to ensure that the claims you make for your products do not reflect intended uses that cause the distribution of the products to violate the Act.”

Like other skin care and alternate therapy companies called out by the FDA, Annimarie Gianni was ordered to take prompt action to correct the violations. Failure to do so may result in enforcement action, injunctions against the manufacturer and distributors, and seizure of the products.

Source: FDA